No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4238281 |
chr13:111596127-111596128 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs557885418 |
chr13:111596131-111596132 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs563762742 |
chr13:111596193-111596194 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs577990914 |
chr13:111596213-111596214 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs139514029 |
chr13:111596235-111596236 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs9522004 |
chr13:111596279-111596280 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs568139131 |
chr13:111596282-111596283 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs182942937 |
chr13:111596287-111596288 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs187534354 |
chr13:111596290-111596291 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs149730216 |
chr13:111596315-111596316 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs539766146 |
chr13:111596350-111596351 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs558035583 |
chr13:111596391-111596392 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs192392454 |
chr13:111596459-111596460 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs184869305 |
chr13:111596489-111596490 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs2005632 |
chr13:111596511-111596512 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs2001187 |
chr13:111596527-111596528 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs534942920 |
chr13:111596568-111596569 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs553168424 |
chr13:111596582-111596583 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs573593460 |
chr13:111596587-111596588 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs113641136 |
chr13:111596594-111596595 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs2005633 |
chr13:111596595-111596596 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs575997005 |
chr13:111596607-111596608 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs543402630 |
chr13:111596611-111596612 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs147599202 |
chr13:111596618-111596619 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs200712096 |
chr13:111596622-111596623 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs146728976 |
chr13:111596643-111596644 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs528999358 |
chr13:111596648-111596649 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs376144912 |
chr13:111596688-111596689 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs188955035 |
chr13:111596704-111596705 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs192632171 |
chr13:111596715-111596716 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs533118666 |
chr13:111596721-111596722 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs551738771 |
chr13:111596840-111596841 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs2001678 |
chr13:111596868-111596869 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs530563003 |
chr13:111596880-111596881 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs537076548 |
chr13:111596909-111596910 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs76684339 |
chr13:111596911-111596912 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs139275102 |
chr13:111596930-111596931 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs184479197 |
chr13:111596936-111596937 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs113859743 |
chr13:111596938-111596939 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs577827961 |
chr13:111596967-111596968 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs538840004 |
chr13:111597032-111597033 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs189706686 |
chr13:111597038-111597039 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs570410485 |
chr13:111597096-111597097 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs377674612 |
chr13:111597097-111597098 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs114736919 |
chr13:111597113-111597114 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs2001677 |
chr13:111597116-111597117 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs114428898 |
chr13:111597186-111597187 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs117985021 |
chr13:111597193-111597194 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs541135351 |
chr13:111597228-111597229 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs559480922 |
chr13:111597318-111597319 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|